|
[1]
|
Salazar, F.J., Granger, J.P., Joyce, M.L.M., Burnett, J.C., Bove Jr., A.A. and Romero, J.C. (1986) Effects of hypertonic saline infusion and water drinking on atrial peptide. American Journal of Physiology, 251, R1091-R1094.
|
|
[2]
|
Laine, M., Arajama, O., Voulteenaho, O., Ruskoaho, H. and Weckstrom, M. (1994) Block of stretch-activated atrial natriuretic peptide secretion by gadolinium in isolated rat atrium. The Journal of Physiology, 480, 553-561.
|
|
[3]
|
Clark, B.A., Sclater, A., Epstein, F.H. and Elahi, D. (1993) Effect of glucose, insulin, and hypertonicity on atrial natriuretic peptide levels in man. Metabolism, 42, 224-228.
doi:10.1016/0026-0495(93)90040-U
|
|
[4]
|
Ohno, Y., Suzuki, H., Yamakawa, H., Nakamura, M., Kato, Y. and Saruta, T. (2001) Correlation of sodium-related factors with insulin sensitivity in young, lean, male offspring of hypertensive and normotensive subjects. Journal of Human Hypertension, 15, 393-399.
doi:10.1038/sj.jhh.1001211
|
|
[5]
|
Tanabe, A., Naruse, M., Wasada, T., Naruse, K., Yoshimoto, T., Omori, Y. and Demura, H. (1995) Effects of acute hyperinsulinemia on plasma atrial and brain natriuretic peptide concentrations. European Journal of Endocrinology, 132, 693-698. doi:10.1530/eje.0.1320693
|
|
[6]
|
Bohlen, L., Ferrari, P., Papiri, M., Allemann, Y., Shaw, S. and Wiedmann, P. (1994) Atrial natriuretic factor increases in response to an acute glucose load. Journal of Human Hypertension, 12, 803-807.
|
|
[7]
|
Reddy, S., Kelly, D., Cocineas, C. and Gyory, Z. (1988) Additive and synergistic interaction of atrial natriuretic peptide and volume expansion. American Journal of Physiology, 255, F66-F73.
|
|
[8]
|
Ationu, A., Burch, M., Singer, D., Littleton, P. and Carter, N. (1993) Cardiac transplantation affects ventricular expression of brain natriuretic peptide. Cardiovascular Research, 27, 188-191. doi:10.1093/cvr/27.2.188
|
|
[9]
|
Geny, B., Piquard, F., Follenius, M., Thiranos, J.C., Charpentier, A., Epailly, E., Levy, F., Kretz, J.G., Eisenmann, B. and Haberey, P. (1998) Endothelin participates in increased circulating atrial natriuretic peptide early after human heart transplantation. The Journal of Heart and Lung Transplantation, 17, 167-175.
|
|
[10]
|
Weston, M.W., Cintron, G.B., Giordano, A.T. and Vesely, D.L. (1994) Normalisation of circulating atrial natriuretic peptides in cardiac transplant recipients. American Heart Journal, 127, 129-142.
doi:10.1016/0002-8703(94)90518-5
|
|
[11]
|
Starling, R.C., O’Dorisio, T.M., Malarkey, W.B., Murray, K.D., Myerowitz, P.D. and Cody, R.J. (1991) Preserved atrial natriuretic peptide secretory function after cardiac transplantation. American Journal of Cardiology, 68, 237- 241.
|
|
[12]
|
Benedini, S., Fiocchi, R., Battezzati, A., et al. (2007) A-trial natriuretic peptide in diabetic and nondiabetic patients with and without heart transplantation. Transplantation Proceedings, 39, 1580-1585.
doi:10.1016/j.transproceed.2007.04.020
|
|
[13]
|
Patel, K.P. (1997) Volume reflex in diabetes. Cardiovascular Research, 34, 81-90.
doi:10.1016/S0008-6363(97)00012-6
|
|
[14]
|
Oliveira, V.L., Moreira, E.D., Farah, V.M., et al. (1999) Cardiopulmonary reflex impairment in experimental dia- betes in rats. Hypertension, 34, 813-817.
doi:10.1161/01.HYP.34.4.813
|
|
[15]
|
Beretta-Piccoli, C., Elshater-Zanetti, F., Shaw, S., et al. (1994) Acute sodium loading in patients with uncomplicated diabetes mellitus: Renal and hormonal effects. Clinical Science, 86, 383-390
|
|
[16]
|
Salas-Ramirez, M., Ariza Andraca, R., Frati Munari, A., et al. (1995) Effect of plasma volume expansion on auri-cular natriuretic peptide in non-dependent insulin diabetic patients with autonomic neuropathy. Archives of Medical Research, 26, 35-40.
|
|
[17]
|
Trevisan, R., Fioretto, P., Semplicini, A., et al. (1990) Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during iso-tonic volume expansion. Diabetes, 39, 289-298.
doi:10.2337/diabetes.39.3.289
|
|
[18]
|
Sechi, L., Valentin, J.P., Griffin, C.A., et al. (1995) Receptors for atrial natriuretic pep-tide are decreased in the kidney of rats with streptozocin-induced diabetes mellitus. The Journal of Clinical Investigation, 95, 2451-2457.
doi:10.1172/JCI117945
|
|
[19]
|
Asakawa, M., Takano, H., Nagai, T., et al. (2002) Peroxi-some proliferator-activated receptor-gamma plays a cri- tical role in inhibition of cardiac hyper-trophy in vitro and in vivo. Circulation, 105, 1240-1246.
doi:10.1161/hc1002.105225
|
|
[20]
|
Duan, S.Z., Ivashchenko, C.Y., Russel, M.W., et al. (2005) Cardiomyocyte-specific knockout and agonist of peroxi-some proliferators-activated receptor-gamma both induce cardiac hypertrophy in mice. Circulation Research, 97, 372- 379. doi:10.1161/01.RES.0000179226.34112.6d
|
|
[21]
|
Waugh, J., Keating, G.M., Plosker, G.L., Easthope, S. and Robinson, D.M. (2006) Pioglitazone: A review of its use in type 2 diabetes mellitus. Drugs, 66, 85-109.
doi:10.2165/00003495-200666010-00005
|
|
[22]
|
Rennings, A.J., Smits, P., Stewart, M.W., et al. (2006) Fluid retention and vascular effects of rosiglitazone in obese, insulin-resistant, nondiabetic subjects. Diabetes Care, 29, 581-587.
doi:10.2337/diacare.29.03.06.dc05-01467
|
|
[23]
|
Zanchi, A., Chiolero, A., Maillard, M., et al. (2004) Effects of the peroxisome proliferators-activated receptor-gamma agonist Pioglitazone on renal and hormonal responses to salt in healty men. The Journal of Clinical Endocrinology & Metabolism, 89, 1140-1145.
doi:10.1210/jc.2003-031526
|
|
[24]
|
Decaux, G., Dumont, I., Naeije, N., et al. (1982) High uric acid clearance in cirrhosis secondary to increased “effective vascular volume”. American Journal of Medicine, 73, 328-334.
doi:10.1016/0002-9343(82)90718-5
|
|
[25]
|
Weinman, E.J., Eknoyan, G. and Suki, W.N. (1975) The influence of the extracellular fluid volume on the tubular reabsorption of uric acid. Journal of Clinical Investigation, 55, 283-291. doi:10.1172/JCI107931
|
|
[26]
|
Nesto, R.W., Bell, D., Bonow, R.O., Fonseca, V., Grundy, S.M., Horton, E.S., et al. (2003) Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Asso-ciation and American Diabetes Association. Circulation, 108, 2941-2948.
|
|
[27]
|
Lincoff, A.M., Wolski, K., Nicholls, S.J. and Nissen, S.E. (2007) Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis of randomized trials. JAMA, 298, 1180-1188.
|
|
[28]
|
Erdmann, E. and Wilcox, R.G. (2008) Weighing up the cardiovascular benefits of thiazolidinedione therapy: The impact of increased risk of heart failure. European Heart Journal, 29, 12-20. doi:10.1093/eurheartj/ehm529
|
|
[29]
|
Schernthaner, G., Matthews, D.R., Charbonnel, B., et al. (2004) Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double- blind, randomized trial. The Journal of Clinical Endocrinology & Metabolism, 89, 6068-6076.
doi:10.1210/jc.2003-030861
|
|
[30]
|
St. John Sutton, M., Rendell, M., Dandona, P., et al. (2002) A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes. Diabetes Care, 25, 2058- 2064. doi:10.2337/diacare.25.11.2058
|
|
[31]
|
Goldberg, R.B., Kendall, D.M., Deeg, M.A., et al. (2005) A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. Diabetes Care, 28, 1547-1554.
doi:10.2337/diacare.28.7.1547
|
|
[32]
|
Dormandy, J.A., Charbonnel, B., Eckland, D.J., Erdmann, E., Massi-Benedetti, M., Moules, I.K., Skene, A.M., Tan, M.H., Lefèbvre, P.J., Murray, G.D., Standl, E., Wilcox, R.G., Wilhelmsen, L., Betteridge, J., Birkeland, K., Golay, A., Heine, R.J., Korányi, L., Laakso, M., Mokán, M., Norkus, A., Pirags, V., Podar, T., Scheen, A., Scherbaum, W., Schernthaner, G., Schmitz, O., Skrha, J., Smith, U. and Taton, J., (2005) PROactive investigators. Secondary prevention of macrovascular events in patients with type 2
|
|
[33]
|
Berger, R., Strecker, K., Huelsmann, M., Moser, P., Frey, B., Bojic, A., Stanek, B. and Pacher, R. (2003) Prognostic power of neurohumoral parameters in chronic heart failure depends on clinical stage and observation period. The Journal of Heart and Lung Transplantation, 22, 1037- 1045. doi:10.1016/S1053-2498(02)00560-0
|
|
[34]
|
Ballerman, B.J., Brenner, B.M. and George, E. (1986) Brown memorial lecture. Role of atrial peptides in body fluid homeostasis. Circulation Research, 58, 619-630.
doi:10.1161/01.RES.58.5.619
|
|
[35]
|
Goenka, N., Kotonya, C., Penney, M.D., Randeva, H.S. and O’Hare, J.P. (2008) Thiazolidinediones and the renal and hormonal response to water immersion-induced volume expansion in type 2 diabetes mellitus. American Journal of Physiology—Endocrinology and Metabolism, 294, 733-739. doi:10.1152/ajpendo.00583.2007
|